Evidence map›Paper›PMID 38449675›Full record

ArticleFrontiers in bioengineering and biotechnology2024

Magnetic propelled hydrogel microrobots for actively enhancing the efficiency of lycorine hydrochloride to suppress colorectal cancer.

Fengqi Jiang, Qiuyan Zheng, Qingsong Zhao, Zijuan Qi, Di Wu, Wenzhong Li, Xiaoke Wu, Conghui Han

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Fengqi Jiang *Department of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Qiuyan Zheng *Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qingsong ZhaoPostdoctoral Programme of Meteria Medica Institute of Harbin University of Commerce, Harbin, China.
Zijuan QiDepartment of Pathology, Heilongjiang Provincial Hospital, Harbin, China.
Di WuDepartment of General Surgery, Heilongjiang Provincial Hospital, Harbin, China.
Wenzhong LiDepartment of General Surgery, Heilongjiang Provincial Hospital, Harbin, China.
Xiaoke WuDepartment of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Conghui HanDepartment of Urology, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Heilongjiang Provincial Hospital · CNHarbin Medical University · CNHarbin University of Commerce · CNJiangsu Normal University · CNXuzhou Central Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research and development in the field of micro/nano-robots have made significant progress in the past, especially in the field of clinical medicine, where further research may lead to many revolutionary achievements. Through the research and experiment of microrobots, a controllable drug delivery system will be realized, which will solve many problems in drug treatment. In this work, we design and study the ability of magnetic-driven hydrogel microrobots to carry Lycorine hydrochloride (LH) to inhibit colorectal cancer (CRC) cells. We have successfully designed a magnetic field driven, biocompatible drug carrying hydrogel microsphere robot with Fe

Indexed as

colorectal cancerFe3O4 particlelycorine hydrochloridemagnetic-drivenmicrorobots

Identifiers

PMID38449675
PMCPMC10915283
OpenAlexW4392001683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.